Wuhan, China

Ying Liang

This inventor holds 2 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Waterstone Pharmaceuticals (Wuhan) Co., Ltd., Waterstone Pharmaceuticals(wuhan) Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ying Liang. Retrieved from https://idiyas.com/inventor/ying-liang-o8bwypuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ying Liang in the Field of Hyperuricemia Treatment

Introduction

Ying Liang is a notable inventor based in Wuhan, China. He has made significant contributions to the field of medical science, particularly in the treatment of hyperuricemia. His innovative work has led to the development of a patent that addresses this prevalent health issue.

Latest Patents

Ying Liang holds a patent for "Polymers, compositions and methods for treating hyperuricemia." This patent provides polymers and compositions, as well as methods for preparing such polymers and compositions. It also includes a method of using these polymers or compositions for binding uric acid or its precursors, and for treating hyperuricemia, gout, and diseases caused by hyperuricemia. He has 1 patent to his name.

Career Highlights

Throughout his career, Ying Liang has worked with Waterstone Pharmaceuticals (Wuhan) Co., Ltd. and Waterstone Pharmaceuticals Co., Ltd. His experience in these companies has allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical treatments.

Collaborations

Ying Liang has collaborated with notable colleagues such as Youcheng Zhou and Yan Li. These partnerships have likely enhanced his research and development efforts in the field of polymers and compositions for medical applications.

Conclusion

Ying Liang's contributions to the treatment of hyperuricemia through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, providing new solutions for those affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…